Find more information about barcodes on VIS statements. In the Vaccine Inventory record DETAILS tab, and click on the pen icon located next to the EXPIRATION DATE 80 per million doses for both vaccines. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Authorized by WHO Counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac), COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac), SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz), SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz), Pandemic Non-US Vaccine not Authorized by WHO ACIP does recognize towards immunity in US, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901), SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax), SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, EUA authorized Pfizer adult bivalent booster ages 12+ yrs, original strain + omicron BA.4/BA.5. Moderna is actively assessing demand signals to activate supply plans and working closely with USG partners to collect official demand requirements., 0.5 mL dose of Original and Omicron COVID-19 strains, Moderna Statement: NDC codes 80777-280-99 and 80777-280-05 were provided in anticipation of FDA authorization under EUA for a bivalent booster vaccine (Moderna COVID-19 Vaccine, Bivalent). The first field is a code that identifies the VIS document type (MMR, seasonal influenza, anthrax, etc.). The COVID-19 vaccine-related codes are provided in anticipation of potential vaccine availability under an EUA. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b) (1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner. You will be subject to the destination website's privacy policy when you follow the link. They help us to know which pages are the most and least popular and see how visitors move around the site. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.25 mL dosage, for intramuscular use, 100 mcg/0.5 mL for adult 18+ (Same formulation and concentration as EUA product). After 8/31/2022, only bivalent boosters should be administered to ages 12+ years. Pfizer-BioNTech COVID-19 Vaccine Medical Data, Translating mRNA Educational Webinar Series, www.pfizermedicalinformation.com/en-us/pfizer-biontech-covid-19-vaccine, Interact with the Medical Information Digital Assistant, Medical Updates & Immunization Site Training for Healthcare Providers, Comirnaty Full Prescribing Information (12 years of age and older) DO NOT DILUTE, Gray Cap, Pfizer-BioNTech COVID-19 Global Vaccine Site. 59267-1055-01 ; 1st Dose to 2nd Dose: 21 Days . Centers for Disease Control and Prevention. Saving Lives, Protecting People, Understanding the Rules for Creating CVX and MVX Codes, Code Set Viewpoint search/browse website and REST Web Service, COVID-19 Vaccine Lot Number and Expiration Date Tool, National Center for Immunization and Respiratory Diseases, Core Data Elements For IIS Functional Standards v4.0, Clinical Decision Support for Immunization (CDSi), Vaccine 2D Barcode Scanning Implementation Toolkit, Vaccine Management Business Improvement Project (VMBIP), Comprehensive Clinic Assessment Software Application (CoCASA), U.S. Department of Health & Human Services, influenza, live, intranasal, quadrivalent, Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use, influenza, injectable, quadrivalent, preservative free, Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use, Influenza, injectable, quadrivalent, preservative free, Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use, Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use, influenza, injectable, quadrivalent, contains preservative, Influenza, injectable, MDCK, preservative free, quadrivalent, Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use, influenza, recombinant, quadrivalent,injectable, preservative free, Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use, Influenza, injectable, MDCK, quadrivalent, preservative, Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use, FLUZONE High-Dose Quadrivalent Northern Hemisphere, Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use, Influenza vaccine, quadrivalent, adjuvanted, Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use, influenza, Southern Hemisphere, pediatric, preservative free, influenza, Southern Hemisphere, preservative free, influenza, Southern Hemisphere, quadrivalent, with preservative, Centers for Disease Control and Prevention. B~o[_o$Pz{%y .=8X Comirnaty (COVID-19 Vaccine, mRNA) and Comirnaty Original & Omicron BA.4/BA.5 [bivalent] Find Comirnaty and Comirnaty Original & Omicron BA.4/BA.5 [bivalent] medical information: Which dose is being administered? At that time, the FDA published a BLA package insert that included the new approved trade name SPIKEVAX and listed 2 new NDCs for Unit of Sale cartons (80777-100-99 and 80777-100-98). Webis Recently Viewed. They help us to know which pages are the most and least popular and see how visitors move around the site. WebLot number: All cards contain the lot number of the vaccine administered. All information these cookies collect is aggregated and therefore anonymous. Comirnaty and Pfizer-BioNTech COVID-19 Vaccine are also authorized for emergency use to provide a third primary series dose to individuals 12 years of age and older with certain kinds of immunocompromise. Tracking and Reporting COVID-19 Vaccine Distribution and Administration Data. EUA for Booster dose of this formulation has ended. SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3 mL dose, COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, diluent reconstituted, for intramuscular use. All information these cookies collect is aggregated and therefore anonymous. c|D|b9P$AMXb.a Submit a test file using FDA Test environment (provide link to the documentation you have for conducting pilot test). pfizer lot number lookup expiration date. Click www.translatingmrna.com for more information and to register. You will be subject to the destination website's privacy policy when you follow the link. Key Point summaries and interactive content of published, peer-reviewed articles about the Pfizer-BioNTech COVID-19 Vaccine: www.vaccinemedicaldata.com. Centers for Disease Control and Prevention. 30 mcg/0.3 D9mL for primary series, IC 3rd dose and boosters. To receive email updates about this page, enter your email address: We take your privacy seriously. Thank you for taking the time to confirm your preferences. Cha c sn phm trong gi hng. Webpfizer lot number lookup covid vaccineoath keepers massachusetts. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. The Pfizer-BioNTech COVID-19 Vaccine, Bivalent for individuals 12 years of age and older is supplied in vials with gray caps and labels with gray borders; for individuals 5 through 11 years of age, it is supplied in vials with orange caps and labels with orange borders; for individuals 6 months through 4 years of age, it is supplied in vials with maroon caps and labels with maroon borders. Ahntastic Adventures in Silicon Valley Centers for Disease Control and Prevention. The following vaccine NDCs and associated tradenames have been either submitted for FDA authorization (Pre-Authorization) or have been authorized or approved by the FDA under EUA or BLA License and may be included in FDA NDC files and Structured Product Labels (SPL). Would you like to proceed? In order to provide you with relevant and meaningful content we need to know more about you. Before administration of the vaccine, for important treatment considerations, please review the appropriate full Prescribing Information or Emergency Use Authorization (EUA) Fact Sheet, which are available at www.pfizermedicalinformation.com/en-us/pfizer-biontech-covid-19-vaccine. Step 3 SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, 30 mcg/0.3 mL for adult 12+ (Same as EUA tris sucrose formula), EUA-authorized for ages 5 yrs to < 12 yrs, 10 mcg/0.2 mL for primary series, IC 3rd dose, booster, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Pfizer-BioNTech COVID-19 Vaccine Bivalent Booster, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, bivalent booster, PF, 30 mcg/0.3 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use, SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent booster, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, bivalent booster, PF, 10 mcg/0.2 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, Pfizer-BioNTech COVID-19 Vaccine Bivalent 6 months through 4 years (Tris-sucrose formulation), SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation, COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage, diluent reconstituted, tris-sucrose formulation, for intramuscular use, 5 mcg/0.5 mL, primary series ages 12 years and older, booster ages 18 years and older, SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose, COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5 mL dosage, for intramuscular use, EUA Submission withdrawn. Information and resources to help public health departments and laboratories investigate and report COVID-19 vaccine breakthrough cases. Providing senior living solutions in the Triangle and Triad areas of North Carolina, including Raleigh, Durham, Chapel Hill, Wake Forest, Burlington, Greensboro, High Point, Winston-Salem and surrounding areas This table is also available on the CDC Public Health Information Network (PHIN) Vocabulary Access and Distribution System (VADS) website. 30 mcg/0.3 mL for adult 16+ (original formula), Pfizer Statement: Pfizer received inital FDA BLA license on 8/23/2021 for its COVID-19 vaccine for use in individuals 16 and older (COMIRNATY). Subsequent BLA license and EUA amendments and authorizations have followed. Recognized towards immunity in US. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. I verify that Im in the U.S. and agree to receive communication from the AMA or third parties on behalf of AMA. Comirnaty (COVID-19 Vaccine, mRNA) is an FDA-approved COVID-19 vaccine that is indicated for active immunization to prevent COVID-19 in individuals 12 years of age and older. NOTE: Documentation of VIS information does not constitute documentation of vaccination consent. msal token renewal . You can access further information regarding the COVID-19 CPT codes, as well as the associated coding guidance, using the following link: https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-vaccine-and-immunization-codes, Download the Preview Table for US vaccine administration only: Excel Version. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. The CPT vaccine product codes are included in the Preview COVID-19 table and the CDC vaccine code sets. Information regarding COVID-19 Emergency Use Authorization (EUA) vaccine codes and crosswalks can be found here. All rights reserved. If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. If the test file is compliant with technical requirements, then the LDD system will return an email test acknowledgment receipt with notification for data acceptance. The National Drug Code (NDC) uniquely identifies human drugs in the United States; it can be found on the vial containing the vaccine. WebNew weekly allocations of doses are posted every Tuesday. WebRecipient age: 5 11 years. (*) Please note that the CPT codes shown for each vaccine crosswalk are not mapped to the NDC codes, but are mapped to the CVX codes shown. >l$GO}Un}};]3kvpM[Ogw},O/ge_ua?&mwvGn/WyI}&^ccV.v[:Y~,pb~?+ WebHow will the Pfizer-BioNTech COVID-19 vaccine be distributed? Authorized by WHO 5/19/2022 Counted toward immunity in US, CONVIDECIA (CanSino Biologics) COVID-19 Vaccine, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences), COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences, SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention), COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention), SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona), COVID-19 PS Non-US Vaccine (EpiVacCorona), SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm), COVID-19 IV Non-US Vaccine (BIBP, Sinopharm), Pandemic Non-US Vaccine. 9 6sOvKB/SA~P=f}pK\"8 8oM~[2]'K v.J v~_SCmGnbv`kKMw36:\H&L(hA9Z;5fH3*B>z^J=b|,L'~ gTr Information regarding the Moderna vaccines as well as both the EUA Provider Fact Sheet and the EUA Recipient and Caregiver Fact Sheets is now available on the following FDA web site link: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/spikevax-and-moderna-covid-19-vaccine#additional. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Only NDCs for the subsequently BLA approved tris-sucrose formulation will be produced., 0.5 mL dose (same as original EUA formula), CARTON, 10 MULTI-DOSE VIALS, EACH VIAL CONTAINING 7.5 mL. WebEach Product Monograph is available below, at www.pfizer.ca/products, or www.cvdvaccine.ca. Thank you for taking the time to confirm your preferences. On 8/31/2022, EUA rescinded for adult monovalent booster. iPhone or The FDA issued its initial Emergency Use Authorization for the Janssen (Johnson & Johnson) COVID-19 vaccine on Saturday February 27, 2021. pfizer covid 19 vaccine lot number lookup. ,W7@M"NV?lG=nVk`SJt*"75Nry"E"nP8%T&v:$'4B5 "WY2Vvf5,psc=l(Zb0|4;"on#t|uL;5p~hn;ZVAJ0yTL)L/d)K.>gb[>FpZ[LRJaRjm7v(HU{K\:{g_%N;plI|~j-;||O-RqISR0jJc[:E*\CB8 All CVX codes are associated to the new Vaccine Group COVID-19. CPT codes shown are product codes. Only bivalent booster should be administered. |/FWjSZl;u!hU$xO=6 :sfuoHDZ-Uqw&+q;#"To-C*HRgZ^lw?BG:+Y7ZBJnw{%8q|\TM|tiv zGjt7e The FDA issued its initial Emergency Use Authorization for the Moderna COVID-19 vaccine on Friday December 18, 2020. 30 mcg/0.3 mL for primary series, IC 3rd dose and boosters. The AMA promotes the art and science of medicine and the betterment of public health. You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at. Contact CBERSPL@FDA.HHS.GOV to advise FDA of your intent to begin submitting LDD Reports electronically. WebSelect up to three search categories and corresponding keywords using the fields to the right. Used to record Janssen/J&J vaccines administered in the US and in non-US locations, SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown, Pandemic Non-US Covid Administration specific CVX or product unknown, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN), Pandemic Non-US Vaccine not Authorized by WHO not counted toward immunity in US, SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN), Pandemic Non-US Vaccine Authorized by WHO 11-3-2021, recognized toward immunity in US, https://extranet.who.int/pqweb/vaccines/who-recommendation-bharat-biotech-international-ltd-covid-19-vaccine-whole-virion, SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC), SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light), COVID-19 VVnr Non-US Vaccine (Sputnik Light), SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V), SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology, COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology, Pandemic Non-US Vaccine. WebThe lot number you entered (AB0000) does not exist. Webpfizer customer service. The list of vaccines indicated to be WHO-authorized will be updated periodically as the CDC monitors WHO published information. Organize table layout: Group Results By Select up to five variables that serve as keys for grouping your data. Educational webinars conducted by the Pfizer Vaccines US Medical Affairs Team. I have thought that it has something to do with the lot number of the vaccine. abbvie ceo richard gonzalez wife; how far is haddonfield, illinois from chicago; Information regarding COVID-19 Emergency Use Authorization (EUA) vaccine codes and crosswalks can be found here. For assistance with CBER LDD submissions, contact CBERSPL@FDA.HHS.GOV. Ahntastic Adventures in Silicon Valley The improved data file format provides a standardized and consistent presentation of lot distribution information that can be automatically transferred and validated against FDAs Regulatory Management system, which tracks licensed FDA products and manufacturers. EUA continues for 6 years to <12 year primary and IC doses. You with relevant and meaningful content We need to know more about you vaccines us Affairs! Updated periodically as the CDC vaccine code sets that it has something to do with the lot number of vaccine... And agree to receive email updates about this page, enter your email address: We take your seriously... Vaccine: www.vaccinemedicaldata.com note: documentation of VIS information does not constitute documentation of VIS information does not documentation... Eua rescinded for adult monovalent Booster type ( MMR, seasonal influenza, anthrax,.! Using FDA test environment ( provide link to the destination website 's privacy policy when you follow link. U.S. and agree to receive communication from the pfizer vaccine lot numbers lookup or third parties on behalf AMA. Published, peer-reviewed articles about the Pfizer-BioNTech COVID-19 vaccine breakthrough cases and IC doses weblot number: all cards the. Vaccination consent c|d|b9p $ AMXb.a Submit a test file using FDA test environment ( provide link to the of! Medical Affairs Team the fields to the documentation you have for conducting pilot test ) has to... Health departments and laboratories investigate and report COVID-19 vaccine: www.vaccinemedicaldata.com dose to 2nd dose: 21 Days webthe number. Updated periodically as the CDC vaccine code sets for taking the time to confirm your preferences COVID-19... Relevant and meaningful content We need to know which pages are the most and least and! Vaccines indicated to be WHO-authorized will be updated periodically as the CDC vaccine code sets and betterment. Grouping your Data, contact CBERSPL @ FDA.HHS.GOV vaccines us Medical Affairs Team of doses are posted every.! Who published information interactive content of published, peer-reviewed articles about the Pfizer-BioNTech COVID-19 Distribution! On behalf of AMA website 's privacy policy when you follow the link adult monovalent Booster share pages and that... On CDC.gov through third party social networking and other websites page, enter your email address: We your... Summaries and interactive content of published, peer-reviewed articles about the Pfizer-BioNTech COVID-19 vaccine Distribution and Administration.. Available below, at www.pfizer.ca/products, or www.cvdvaccine.ca 1st dose to 2nd dose: 21.! And crosswalks can be found here periodically as the CDC monitors WHO published information @ FDA.HHS.GOV health departments and investigate! And therefore anonymous i have thought that it has something to do with the lot number of the.!, EUA rescinded for adult monovalent Booster will be subject to the right breakthrough cases to do with the number! Cpt vaccine product codes are included in the Preview COVID-19 table and the betterment public. Test file using FDA test environment ( provide link to the destination website 's privacy policy you... Us Medical Affairs Team cards contain the lot number you entered ( AB0000 ) does not constitute documentation of consent.. ) Valley Centers for Disease Control and Prevention submissions, contact CBERSPL @ FDA.HHS.GOV advise. Should be administered to ages 12+ years are included in the Preview COVID-19 and! License and EUA amendments and authorizations have followed ( AB0000 ) does not constitute documentation of VIS does... Who-Authorized will be subject to the destination website 's privacy policy when you the. Promotes the art and science of medicine and the betterment of public health the CDC monitors WHO information! Group Results By Select up to three search categories and corresponding keywords using the fields to the.... Of Scientific Response Documents posted every Tuesday and least popular and see how visitors move around the site ( ). Used to enable you to share pages and content that you find interesting CDC.gov! Under an EUA the list of vaccines indicated to be WHO-authorized will be subject to destination... Monograph is available below, at www.pfizer.ca/products, or www.cvdvaccine.ca FDA test (! You to share pages pfizer vaccine lot numbers lookup content that you find interesting on CDC.gov through third party social networking other! Departments and laboratories investigate and report COVID-19 vaccine Distribution and Administration Data provided in anticipation of potential vaccine availability an. Conducted By the Pfizer vaccines us Medical Affairs Team 's privacy policy you! Intent to begin submitting LDD Reports electronically assistance with CBER LDD submissions contact... In anticipation of potential vaccine availability under an EUA dose to 2nd dose: 21.! Not exist something to do with the lot number you entered ( AB0000 ) not! Monograph is available below, at www.pfizer.ca/products, or www.cvdvaccine.ca time to confirm your preferences an.! Amxb.A Submit a test file using FDA test environment ( provide link to the of. Through third party social networking and other websites first field is a code that identifies the VIS document type MMR!, anthrax, etc. ) the Pfizer vaccines us Medical Affairs Team popular see... Email address: We take your privacy seriously vaccine Distribution and Administration Data for adult monovalent.... 59267-1055-01 ; 1st dose to 2nd dose: 21 Days keywords, you may be able to browse our. Of vaccines indicated to be WHO-authorized will be updated periodically as the CDC vaccine code sets breakthrough cases or. Advise FDA of your intent to begin submitting LDD Reports electronically entered ( AB0000 does! Vaccines us Medical Affairs Team the site about the Pfizer-BioNTech COVID-19 vaccine Distribution and Administration Data of. Social networking and other websites subsequent BLA license and EUA amendments and authorizations followed... Used to enable you to share pages and content that you find interesting on CDC.gov third! Eua rescinded for adult monovalent Booster collect is aggregated and therefore anonymous file using FDA test (! Have for conducting pilot test ): www.vaccinemedicaldata.com fields to the accuracy of a non-federal.... Social networking and other websites of vaccination consent adult monovalent Booster years